Major Shareholder's Stake Diluted from 22.1% to 6.5% Due to Company Share Issuance

summarizeSummary

A major individual shareholder, Christian Glibert, reported a significant dilution of his stake in ENvue Medical, Inc. from 22.1% to 6.5%, caused by the company's issuance of additional shares, not by his own sales.

check_boxKey Events · Ownership and Investor Activity · FEED

• Significant Shareholder Dilution

  Christian Glibert's beneficial ownership in ENvue Medical, Inc. decreased from approximately 22.1% to 6.5% of the outstanding common stock.

• Company Share Increase Caused Dilution

  The reduction in ownership percentage was a direct result of the Issuer's total shares outstanding increasing from 1,088,192 to 3,700,908, as reported in the company's recent 10-K filing.

• No Insider Sales

  The reporting person, Christian Glibert, has not acquired or disposed of any shares since the initial Schedule 13D filing; the change is solely due to company-level dilution.

• Reinforces Financial Distress

  This filing quantifies the impact of the company's share issuance, which likely stems from the severe financial distress and going concern warning disclosed in the 10-K filed two days prior.

auto_awesomeAnalysis · FEED · Industrial Applications And Services

This Schedule 13D/A filing confirms the significant dilution that has occurred at ENvue Medical, Inc., impacting a major individual shareholder, Christian Glibert. While Glibert did not sell any shares, his beneficial ownership percentage dropped from 22.1% to 6.5% due to a substantial increase in the company's total shares outstanding. This filing directly follows the recent 10-K, which highlighted severe financial distress and a going concern warning, suggesting the share issuance was likely a capital-raising effort. The drastic dilution of a significant shareholder's stake underscores the challenging financial position of the company and the cost of its capital-raising activities for existing investors.